Employees from AbbVie’s manufacturing facility in Westport celebrating the company being recognised as one of Ireland’s best workplaces. From left: Stella Naughton, Stephanie O'Hara, Louise Casey and Megan McCabe.

Mayo's AbbVie recognised at Great Place to Work Awards

ABBVIE, the global biopharmaceutical company which employs more than 1,400 in Westport, has been listed as one of the best places to work in Ireland at the 20th annual Great Place to Work 2022 Awards.

It is the ninth consecutive year that the company has featured on the list and first time since the company acquired Allergan in 2020 that all the company’s Irish sites took part in the anonymous workplace experience survey.

AbbVie, which employs approximately 2,600 people across eight sites in Ireland, was ranked 12th Best Large Company in Ireland at the awards.

The Great Place to Work Institute assesses the policies and practices in place in organisations under nine key areas, including employee development, hiring practices, employee achievement recognition, and communication. It then benchmarks these against other organisations in each country.

The Institute also recognised AbbVie as a Best Workplace for Women for the fourth successive year. AbbVie is one of just 27 companies in Ireland to receive this accolade in 2022. The programme recognises organisations that create a positive and supportive work environment for women to develop personally and professionally.

AbbVie’s country HR director, Samantha Commons, said: “I’m very proud that AbbVie has been included in this prestigious list again this year and delighted that this recognition includes our new AbbVie sites in Dublin and Westport. I’m equally delighted that AbbVie has also been awarded Best Workplaces for Women certification, reflecting our commitment to empower female colleagues to reach their full potential.

“A big thank you to our dedicated employees working at our sites across Ireland for their ongoing commitment to develop and grow our business. They continue to demonstrate the very best of our inclusive company culture and ensure an uninterrupted supply of vital medicines for patients around the world.”